5 курс / Госпитальная педиатрия / Острый лейкоз

11.Müller H., Boos J. Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol, 1998; 28: 97–113.

12.A.Karachunskiy, R.Herold, A. von Stackelberg, et al. Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia, 2008, 22(6):1144-1153

13.A Karachunskiy, J Roumiantseva, S Lagoiko et al. Efficacy and toxicity of dexamethasone vs methylprednisolone – long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002. Leukemia 2015, 29(9): 1955-8

14.Schultz KR, Bowman WP, Aledo A, et al. Continuous dosing Imatinib with intensive chemotherapy gives equivalent outcomes to allogeneic BMT for Philadelphia chromosomepositive (Phю) acute lymphoblastic leukemia (ALL) with longer term follow up: Updated

Results of Children’s Oncology Group (COG) AALL0031. Pediatr Blood Cancer

2010;54:788.

15.Leoni V, Biondi A. Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia. Haematologica, 2015; 100(3): 295-299

16.Cooper SL, Brown PA. Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):61-73.

17.Pui CH, Evans WE. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol. 2013;50(3):185-96.Щукин В.В. — М.: ГЭОТАР-Медиа, 2015.

— 656 с.

71